Actify Neurotherapies

Actify Neurotherapies was a leading network of outpatient mental health clinics specializing in interventional psychiatry, particularly the administration of intravenous ketamine infusion therapy. Founded by Dr. Steve Levine, the company was a pioneer in providing rapid-acting treatments for treatment-resistant depression, anxiety, and PTSD. In 2019, Actify was acquired by Greenbrook TMS, a major provider of Transcranial Magnetic Stimulation, to expand the availability of specialized depression treatments across the United States. The company focused on evidence-based protocols to ensure patient safety and efficacy in the delivery of ketamine and esketamine treatments. Following the acquisition, its operations were integrated into the broader Greenbrook TMS network.